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ABSTRACT 
 
Purpose: Declining inspiratory muscle function and structure and systemic low-level 
inflammation and oxidative stress may contribute to morbidity and mortality during normal 
ageing. Therefore, we examined the effects of inspiratory muscle training (IMT) in older 
adults on inspiratory muscle function and structure and systemic inflammation and oxidative 
stress, and re-examined the reported positive effects of IMT on respiratory muscle strength, 
inspiratory muscle endurance, spirometry, exercise performance, physical activity levels 
(PAL) and quality of life (QoL). Methods: Thirty-four healthy older adults (68  3 years) 
with normal spirometry, respiratory muscle strength and physical fitness were divided equally 
into a pressure-threshold IMT or sham-hypoxic placebo group. Before and after an 8 week 
intervention, measurements were taken for dynamic inspiratory muscle function and 
inspiratory muscle endurance using a weighted plunger pressure-threshold loading device, 
diaphragm thickness using B-mode ultrasonography, plasma cytokine concentrations using 
immunoassays, DNA damage levels in peripheral blood mononuclear cells (PBMC) using 
Comet Assays, spirometry, maximal mouth pressures, exercise performance using a six 
minute walk test, PAL using a questionnaire and accelerometry, and QoL using a 
questionnaire. Results: Compared to placebo, IMT increased maximal inspiratory pressure 
(+34  43%, P = 0.008), diaphragm thickness at residual volume (+38  39%, P = 0.03), and 
peak inspiratory flow (+35  42%, P = 0.049), but did not change other spirometry measures, 
plasma cytokine concentrations, DNA damage levels in PBMC, dynamic inspiratory muscle 
function, inspiratory muscle endurance, exercise performance, PAL nor QoL. Conclusion: 
These novel data indicate that in healthy older adults IMT elicits some positive changes in 
inspiratory muscle function and structure, but does not attenuate systemic inflammation and 
oxidative stress, nor improve exercise performance, PAL or QoL. Keywords: inspiratory 
muscle structure, inspiratory muscle function, cytokines, oxidative stress. 
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INTRODUCTION 
Paragraph Number 1 The work of breathing is increased in older adults at rest and during 
exercise. With healthy ageing there is a progressive decrease in total respiratory system 
compliance resulting in flow limitation, air trapping and an increase in residual volume which 
flattens the curvature of the diaphragm, shifting its length-tension relationship to a shorter 
length and placing it at a mechanical disadvantage (21). This contributes to a reduction in 
inspiratory muscle force and endurance, whilst increasing the oxygen cost of breathing (21). 
Functionally, this can contribute to increased dyspnea during everyday tasks, limit exercise 
performance, and lead to reduced physical activity levels (PAL) and quality of life (QoL) (17, 
22).    
 
Paragraph Number 2 Respiratory muscle training in healthy older adults improves 
respiratory muscle strength and endurance,  spirometry measures, exercise tolerance, PAL 
and QoL (3, 4, 19, 43). However, this research has either lacked statistical power (3) or has 
risked participant bias by failing to employ a placebo (PLA) group (4, 19, 43). Inspiratory 
muscle training (IMT) in younger adults also increases respiratory muscle size, as evidenced 
by increases in diaphragm thickness (Tdi) measured with B-mode ultrasonography (13), but 
whether this occurs in older adults is unknown.  
 
Paragraph Number 3 We have recently shown in young healthy adults that increased 
respiratory muscle work at rest increases plasma interleukin-1β (IL-1β) and interleukin-6 (IL-
6) concentrations, and that IMT reduces the plasma IL-6 response to increased respiratory 
muscle work (30, 31). Our data suggest that when the work of breathing is increased, the 
respiratory muscles directly contribute to systemic inflammation and that IMT can reduce the 
evoked plasma IL-6 response. IL-1β can impair striated muscle function (27), whilst both IL-
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1β and IL-6 may have a role in muscle repair and regeneration following injury (40). IL-1β 
can also stimulate myogenesis (12), whereas IL-6 acts to stimulate lipolysis (44), hepatic 
glucose output (14), glucose uptake in the contracting myocytes (10), and satellite cell 
proliferation (25, 40). Ageing is also associated with systemic low-level inflammation and 
oxidative stress, and both may contribute to morbidity and mortality (9, 26). Systemic 
inflammation is linked to arthritis, cancer, and cardiovascular and neurodegenerative disease 
(9), whilst oxidative stress can cause damage to lipids, proteins and nucleic acids (26). 
Whole-body resistance or endurance training in healthy older adults can attenuate resting 
systemic cytokine concentrations (33) and oxidative stress (39). However, whether IMT 
elicits similar effects in older adults remains unknown.  
 
Paragraph Number 4 Therefore, the aim of this study was to examine the effects of IMT in 
healthy older adults on inspiratory muscle function and structure and systemic inflammation 
and oxidative stress, and to re-examine the reported positive effects of IMT on respiratory 
muscle strength, inspiratory muscle endurance, spirometry, exercise performance, PAL and 
QoL.   
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METHODS 
Participants 
Paragraph Number 5 Thirty-six participants aged 65-75 years were recruited according to 
the exclusion criteria used to define “healthy” older participants for exercise studies (16). 
Participants arrived at the laboratory after an overnight fast (morning visits) or 4 h 
postprandially (afternoon visits) having abstained from alcohol and caffeine for 24 h before 
testing.  
 
Experimental design 
Paragraph Number 6 The study adopted a randomized, PLA-controlled design. All 
procedures were conducted in accordance with the Declaration of Helsinki, and the study was 
approved by the Nottingham Trent University Human Ethics Committee. Before 
experimental trials, all participants undertook a screening and familiarization session. In the 
screening session, height, body mass, blood pressure, spirometry and maximal mouth 
pressures were measured according to published guidelines (2, 29) and a full 12-lead 
electrocardiogram was performed. At least 1 week later, participants undertook a 
familiarization session of all testing procedures. For the experimental trials, participants 
attended the laboratory on two separate occasions, separated by 7 days, at the same time of 
day before and after an 8 week intervention. During the first visit, spirometry and maximal 
mouth pressures were measured and participants performed a six minute walk test (6MWT) 
and completed a questionnaire to determine QoL. Participants were also given an 
accelerometer to measure PAL, and were re-familiarized with the testing procedures for the 
second visit. During the second visit, participants returned the accelerometer, a blood sample 
was taken and body fat, Tdi, dynamic inspiratory muscle function and inspiratory muscle 
endurance were assessed. Participants also completed a questionnaire to measure PAL. 
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Participants were then randomly, and equally, divided into an IMT or PLA group. 
Randomization was concealed from the participants. One week before the end of the 
intervention, participants were re-familiarized with all the testing procedures. Following the 
intervention, participants repeated the experimental trials in the same order.  
 
Maximal dynamic inspiratory muscle function 
Paragraph Number 7 Maximal dynamic inspiratory muscle function was assessed as 
described previously (37, 38) using a weighted plunger threshold loading device (24). 
Maximal inspiratory pressure at zero flow (P0max) was initially measured. The maximal value 
recorded for both inspiratory pressure (P0) and flow (V̇I) at each %P0 was used for analysis. 
Inspiratory muscle power (ẆI) was calculated as the product of P0 and V̇I. The maximum rate 
of inspiratory pressure development (MRPD) was assessed during an inspiratory effort at 
P0max.  
 
Inspiratory muscle endurance  
Paragraph Number 8 Inspiratory muscle endurance was assessed as described previously 
using a weighted plunger threshold loading device (24). Loading started at 10 (males) or 5 
(females) cmH2O and was increased by 5 cmH2O every minute until task failure. An audio 
metronome paced breathing frequency (15 breaths·min-1) and duty cycle (0.5).  
 
Diaphragm thickness 
Paragraph Number 9 Tdi was assessed using B-mode ultrasonography (Phillips ATL HDI 
5000; ATL Ultrasound, Washington, USA) according to published guidelines (2). 
Measurements were obtained in triplicate at residual volume (Tdi.RV) and total lung capacity 
(Tdi.TLC) and during a Müeller maneuver from residual volume (Tdi.CONT). The diaphragm 
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thickening ratio (Tdi.TR) was calculated as: Tdi.RV / Tdi.CONT. Lung volumes were estimated 
from flow signals measured using a Fleisch no. 3 pneumotachograph. Ultrasound images 
were synchronized with flow signals using a custom-built trigger.  
 
Six minute walk test 
Paragraph Number 10 Exercise performance was assessed using a 6MWT according to 
published guidelines (1, 8). After the test, measurements were immediately taken for cardiac 
frequency (fC) and estimated arterial oxygen saturation (SpO2) using fingertip pulse oximetry 
(Model 8600; Nonin, Minnesota, USA), and rating of perceived exertion (RPE) for dyspnea 
and leg discomfort using Borg’s modified CR10 scale (5).  
 
Accelerometry 
Paragraph Number 11 Accelerometry was measured (Model GT1M; Actigraph 
Manufacturing Technology, Florida, USA) for 7 days during waking hours according to 
published guidelines (32). The accelerometer was removed for sleep and bathing only. Based 
on previous work (11), data were reduced to provide bands of PAL.  
 
Percentage body fat and questionnaires 
Paragraph Number 12 Percentage body fat was measured using bioelectrical impedance 
(Bodystat 1500; Bodystat, Isle of Man, UK) according to published guidelines (28). PAL and 
QoL were evaluated using the Physical Activity Scale for the Elderly (PASE) (42) and the 
Older People's Quality of Life Questionnaire (OPQOL-35) (7), respectively. Both PASE and 
OPQOL-35 are scored so that higher scores equate to a higher PAL or QoL, and total scores 
from all the components of the questionnaires can range from 0->400 and 35-175, 
respectively. 
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Collection of blood for assays and isolation of peripheral blood mononuclear cells 
Paragraph Number 13 Whole blood samples (~10 mL) were taken at rest from an 
antecubital vein. Blood was immediately transferred into pre-cooled tubes (SARSTEDT, 
Leicester, UK) containing either EDTA for plasma cytokines or lithium heparin for 
peripheral blood mononuclear cells (PBMC), which were isolated using density gradient 
centrifugation as described previously (31). 
 
Plasma cytokine assay 
Paragraph Number 14 Plasma cytokine concentrations were measured in duplicate using an 
ultrasensitive electrochemiluminescence multiplex immunoassay (Meso Scale Discovery, 
Maryland, USA). To exclude inter-assay variation, baseline and post-intervention cytokines 
from both groups were measured during the same assay. The intra/inter-assay coefficient of 
variation (CV) were 10% and 14%, respectively. If the lowest limit of detection was not met 
from the cytokine analyses, participant data (from baseline and post-intervention) were 
excluded from the analysis.  
 
Measurement of systemic oxidative stress 
Paragraph Number 15 Systemic oxidative stress was determined using the Comet Assay 
which measures oxidative DNA damage in PBMC. DNA damage (DNA single strand breaks 
and alkali labile lesions) in PBMC was determined in duplicate using the alkaline Comet 
Assay and the modified alkaline Comet Assay as described previously (31). The inter-assay 
CV was <10%.  
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Inspiratory muscle training and placebo interventions 
Paragraph Number 16 The intervention lasted 8 weeks. The IMT group performed 30 
consecutive dynamic inspiratory efforts twice daily using an inspiratory pressure-threshold 
device (POWERbreathe® Classic series 1st generation; Gaiam Ltd, Southam, UK). The initial 
training load was 50% maximal inspiratory pressure (MIP). Thereafter, participants 
periodically increased the load so that 30 maneuvers could only just be completed. Each 
inspiratory effort was initiated from residual volume and participants strove to maximize tidal 
volume. This regimen is known to be effective in eliciting an adaptive response (23, 30, 37). 
The PLA group used a sham hypoxic trainer which was identical to that used by the IMT 
group, except that the resistance spring was removed and the lower chamber was loosely 
packed with aquarium gravel, which was promoted to the participants as being oxygen 
absorbent, thus reducing the oxygen content of inspired air and mimicking altitude exposure 
(23). Participants were instructed to breathe normally for 30 consecutive breaths twice daily 
through the device and to not increase their normal breathing effort. The resistance of the 
device was <5 cmH2O, a pressure known to elicit negligible changes in inspiratory muscle 
function (38). Spirometry and maximal mouth pressures were assessed at 2 and 4 weeks 
during the intervention. During these visits, correct training technique and load (to ensure it 
was maintained at 50% MIP) was evaluated in both IMT and PLA groups and the “oxygen 
absorbent” gravel in the PLA device was also replaced. During the post-intervention period 
the IMT and PLA groups performed their intervention 2 d∙wk-1, which is sufficient to 
maintain improvements in inspiratory muscle function following IMT (37). These 
maintenance sessions were performed 48 h before and 48 h after experimental trials. All 
participants completed a training diary throughout the study to record adherence to the 
prescribed intervention and whole-body training sessions.  
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Statistical analyses 
Paragraph Number 17 Statistical analyses were performed using SPSS for Windows (IBM, 
Illinois, USA). We based our sample size on the resting plasma IL-6 concentrations observed 
in older adults (2.5  0.5 pg∙mL-1) (9) and the reductions observed following IMT in our 
previous studies (30, 31). From this we estimated that a sample size of 16 participants in each 
IMT and PLA group would have a power of 80% to detect a 0.5 pg∙mL-1 reduction in resting 
plasma IL-6 concentrations for an α of 0.05. A repeated measures ANOVA was used to 
analyze the effects of ‘intervention’ (pre- vs. post-‘treatment’) and ‘treatment’ (IMT vs. PLA). 
Main effects of intervention and intervention x treatment interactions were further explored 
by analyzing IMT and PLA groups separately using paired t-tests between baseline and post-
intervention. Reliability was assessed using CV. Statistical significance was set at P < 0.05. 
Results are presented as mean  SD.  
 
 
 
 
 
 
 
 
 
 
11 
 
RESULTS 
Baseline measurements and intervention 
Paragraph Number 18 Results are presented for 34 participants who completed the study. 
Participants had normal spirometry and maximal mouth pressures (Table 2) and physical 
fitness (Table 4). Participant characteristics were unchanged post-intervention (Table 1). 
Compliance with the intervention was excellent with 97  5 (IMT) and 96  7% (PLA) of 
sessions completed. Inspection of training diaries revealed that habitual whole-body exercise 
remained constant in both groups.  
[Table 1] 
 
Spirometry and maximal mouth pressures (Table 2) 
Paragraph Number 19 There were main effects of intervention for forced vital capacity 
(FVC) (P < 0.001), forced expiratory volume in 1 s (FEV1)/FVC (P = 0.01), peak inspiratory 
flow (PIF) (P < 0.001) and MIP (P = 0.001). Subsequent paired t-tests revealed that FVC 
decreased (P = 0.02) and FEV1/FVC increased (P = 0.002) after PLA only. These changes in 
FVC and FEV1/FVC were not different from those after IMT (intervention x treatment 
interactions of P = 0.358 and P = 0.469, respectively). The 26% increase in PIF after IMT (P 
= 0.001) exceeded (intervention x treatment interaction, P = 0.049) the 12% increase 
observed after PLA (P = 0.027). MIP increased from 82  27 cmH2O at baseline to 97  23, 
100  23 and 103  23 cmH2O (P = 0.001) after 2, 4 and 8 weeks of IMT only and these 
changes exceeded those after PLA (intervention x treatment interaction, P = 0.008).  
[Table 2] 
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Dynamic inspiratory muscle function, inspiratory muscle endurance and diaphragm thickness 
(Table 3)  
 
Paragraph Number 20 There were main effects of intervention for P0max (P < 0.001), MRPD 
(P = 0.001) and optimal inspiratory pressure (P0opt) (P = 0.011) and a strong trend for 
maximum inspiratory muscle power (ẆImax) (P = 0.052). Subsequent paired t-tests revealed 
that P0max increased after both IMT (P = 0.001) and PLA (P = 0.023), whereas increases in 
P0opt (P = 0.015) and MRPD (P = 0.004) were observed after IMT only. The changes in P0opt 
and MRPD were not different from those after IMT (intervention x treatment interactions, P 
= 0.057 and P = 0.352, respectively), although there was a trend in P0opt. There was a main 
effect of intervention for inspiratory muscle endurance (P < 0.001) and subsequent paired t-
tests revealed an increase after IMT only (P = 0.001). This change was not different from that 
after PLA (intervention x treatment interaction, P = 0.125). There was a main effect of 
intervention for Tdi.RV (P < 0.001) and Tdi.TR (P = 0.002) and an intervention x treatment 
interaction for Tdi.RV (P = 0.03). Subsequent paired t-tests revealed that Tdi.RV increased (P = 
0.001) whilst Tdi.TR decreased (P = 0.016) after IMT only. The change in Tdi.TR was not 
different from that after PLA (intervention x treatment interaction, P = 0.368).  
[Table 3]  
 
Exercise performance, physical activity levels and quality of life 
Paragraph Number 21 There were no main or interaction effects for any 6MWT 
measurements, apart from an intervention x treatment interaction for fC (P = 0.011) (Table 4). 
Subsequent paired t-tests revealed that fC increased after PLA only (P = 0.014). There were 
no main or interaction effects for QoL or PAL measured with accelerometry and the PASE. 
At baseline the total QoL score was 134  7 and 137  9, and the total PAL score measured 
with PASE was 174  56 and 181  69 in IMT and PLA groups, respectively. Moderate to 
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vigorous physical activity measured by accelerometry was 46  23 and 37  17 counts∙min-1 
at baseline in IMT and PLA groups, respectively. 
[Table 4]  
 
 
Plasma cytokines and DNA damage levels in peripheral blood mononuclear cells 
Paragraph Number 22 Plasma cytokines and DNA damage levels in PBMC were unchanged 
in both groups post-intervention (Table 5). 
[Table 5] 
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DISCUSSION 
Main findings 
Paragraph Number 23 This is first study to examine the effects of IMT in older adults on 
inspiratory muscle function and structure and systemic inflammation and oxidative stress. We 
also re-examined the reported positive effects of IMT on respiratory muscle strength, 
inspiratory muscle endurance, spirometry, exercise performance, PAL and QoL. The main 
findings were that in a population of healthy older adults with normal spirometry, respiratory 
muscle strength and physical fitness and compared to PLA, IMT increased MIP, Tdi.RV and 
PIF, but did not change other spirometry measures, plasma cytokine concentrations, DNA 
damage levels in PBMC, dynamic inspiratory muscle function, inspiratory muscle endurance, 
6MWT distance, PAL nor QoL.  
 
Plasma cytokines and DNA damage in peripheral blood mononuclear cells 
Paragraph Number 24 IMT did not change resting systemic plasma cytokine concentrations 
or DNA damage levels in PBMC. Baseline plasma cytokine concentrations in the present 
study were similar to those previously reported in older adults (9) and the %DNA damage in 
PBMC was greater than we previously reported in younger adults (31), thus demonstrating 
systemic inflammation and oxidative stress in our participants. Whether there was a reduction 
in local cytokines and/or DNA damage levels in PBMC within the inspiratory muscles cannot 
be excluded. A diaphragmatic or intercostal biopsy would allow this area to be explored. 
However, this is a very invasive measurement that requires open surgery or thoracscopy 
under general anaesthesia and, therefore, for these healthy individuals this would be unethical. 
It is possible that the improvements in inspiratory muscle function and structure following 
IMT may not have reached a threshold necessary to elicit a systemic reduction in cytokines 
and/or DNA damage levels in PBMC. Previous studies have shown that whole-body 
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resistance or endurance training can decrease resting systemic cytokine concentrations (33) 
and oxidative stress (39). However, the respiratory muscles only weigh ~960 g (15) and 
represent ~3% of total body mass (36). Thus, IMT only targets a small muscle group and 
although they do contribute to systemic cytokine concentrations during increased respiratory 
muscle work in younger adults (30, 31), IMT appears to not attenuate these under resting 
conditions.  
 
Diaphragm thickness 
Paragraph Number 25 The increase in Tdi.RV after IMT is similar to the 8% increase in Tdi.TLC 
previously reported after 4 weeks of IMT in younger adults (13). Our findings also support 
the 21% increase in type II fiber size in the external intercostals of chronic obstructive 
pulmonary disease patients after 5 weeks of IMT (35). Together these findings suggest that 
IMT elicits a hypertrophic response in the inspiratory muscles. MIP has been widely used in 
IMT studies as an estimate of inspiratory muscle strength. Since MIP is somewhat technique-
dependent, it is argued that IMT-induced increases in MIP primarily reflect a learning effect 
(34). Our data argue against this, and instead suggest that increased Tdi may contribute to an 
increase in MIP.      
 
Spirometry  
Paragraph Number 26 Except for an increase in PIF, spirometry measures were unchanged 
after IMT. This contrasts previous studies reporting increases in vital capacity after voluntary 
isocapnic hyperpnea training (4), and FVC and peak expiratory flow after concurrent 
IMT/expiratory muscle training (43). Belman and Gaesser (4) and Watsford and Murphy (43) 
failed to provide a mechanism for the changes in spirometry, but we suggest that their 
findings reflect a learning effect rather than an adaptation. This notion is supported by the 
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observed increase in PIF and P0max after PLA, despite a rigorous familiarization of the 
maneuvers. Along with the increase in fC following the 6MWT after PLA, this highlights the 
requirement to employ a legitimate placebo group that will impact participant expectation and 
motivation.  
 
Maximal inspiratory pressure 
Paragraph Number 27 The 26% increase in MIP after IMT is consistent with the 21-39% 
increases reported in comparably aged adults (65-71 years) after IMT (3, 19, 43). A rapid 18% 
increase in MIP, suggestive of neural adaptation, was observed after just 2 weeks of IMT in 
the present study. This has been reported previously in younger participants with 14% and 28% 
increases in MIP observed after 1 and 2 weeks of IMT, respectively (3, 18).  
 
Exercise performance  
Paragraph Number 28 The 6MWT distance was unchanged after IMT and PLA. This 
contrasts with other IMT studies reporting improvements in 6MWT distance (19) and 
endurance time during treadmill walking at the first ventilatory threshold (3). These 
discrepancies may be explained by different baseline endurance training status. Huang et al. 
(19) reported a baseline 6MWT distance that was 90  16% of predicted (41), suggesting that 
the cardiorespiratory response may have been limited. Conversely, 6MWT distance in the 
present study was 102-103% of predicted (41). If a functional consequence of IMT is to 
improve 6MWT distance in older adults, then it may be those with a low baseline status that 
show the greatest improvement (6). Indeed, a recent meta-analysis suggests that participants 
with a low baseline physical fitness level experience, compared to trained participants, 
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greater improvements in exercise performance/capacity following respiratory muscle training 
(20).  
 
Physical activity levels 
Paragraph Number 29 PAL was unchanged after IMT. This is the first study to report PAL 
measured with the PASE, but PAL measured with accelerometry has demonstrated increases 
in moderate to vigorous physical activity in six older adults after IMT (3). Aznar-Lain et al. 
(3) attributed this to an increase in exercise intensity as other accelerometry measures were 
unchanged. Since baseline PAL measured with accelerometry and the PASE in the present 
study were higher than those previously reported in older adults (11, 42), this may have 
limited the potential for PAL to increase following IMT.  
 
Quality of life  
Paragraph Number 30 Baseline QoL in the present study was similar to that previously 
reported in older adults (7). The unchanged QoL after IMT contrasts with the findings of 
Huang et al. (19) who observed an increase in the physical subcategory of the SF-36 QoL 
questionnaire. Differences in the type of questionnaire used (SF-36 vs. OPQOL-35), or the 
economical or health (mental and physical) status of participants, could account for these 
discrepancies. 
 
Conclusion 
Paragraph Number 31 In conclusion, IMT in healthy older adults with normal spirometry, 
respiratory muscle strength and physical fitness and compared to PLA, increased MIP, Tdi 
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and PIF, but did not change other spirometry measures, plasma cytokine concentrations, 
DNA damage levels in PBMC, dynamic inspiratory muscle function, inspiratory muscle 
endurance, 6MWT distance, PAL nor QoL. These novel data indicate that the inspiratory 
muscles of healthy older adults are not a major limiting factor to PAL or exercise 
performance, nor do they impact on resting systemic inflammation and oxidative stress. 
Conversely, IMT may exert a greater influence in older adults with inspiratory weakness 
and/or low levels of physical fitness, or patients with chronic obstructive pulmonary disease 
or asthma who experience an elevated work of breathing and systemic inflammation and 
oxidative stress. Such studies remain to be conducted and thus offer an attractive avenue for 
future investigation.  
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